Metro Healthcare Indonesia Tbk PT
IDX:CARE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
75
193
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Metro Healthcare Indonesia Tbk PT
Cash Flow Statement
Cash Flow Statement
Metro Healthcare Indonesia Tbk PT
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||
| Cash Taxes Paid |
(261)
|
0
|
(895)
|
(982)
|
(1 901)
|
(3 795)
|
(3 723)
|
(3 776)
|
(2 560)
|
(666)
|
(1 162)
|
(1 028)
|
(1 325)
|
(3 445)
|
|
| Cash Interest Paid |
(11 306)
|
(14 335)
|
(11 496)
|
(14 289)
|
(18 028)
|
(36 302)
|
(54 409)
|
(69 563)
|
(85 575)
|
(90 853)
|
(90 878)
|
(90 869)
|
(82 139)
|
(71 515)
|
|
| Change in Working Capital |
(108 473)
|
(108 732)
|
(132 127)
|
(131 543)
|
(99 911)
|
(119 102)
|
(126 842)
|
(114 653)
|
(105 164)
|
(87 366)
|
(60 890)
|
(95 575)
|
(115 143)
|
(135 072)
|
|
| Cash from Operating Activities |
50 303
N/A
|
38 243
-24%
|
38 023
-1%
|
31 287
-18%
|
49 782
+59%
|
2 761
-94%
|
(11 812)
N/A
|
(25 726)
-118%
|
(49 269)
-92%
|
(43 073)
+13%
|
(23 026)
+47%
|
(71 022)
-208%
|
(83 033)
-17%
|
(114 295)
-38%
|
|
| Investing Cash Flow | |||||||||||||||
| Capital Expenditures |
(522 268)
|
(513 407)
|
(625 048)
|
(720 679)
|
(310 405)
|
(325 402)
|
(222 120)
|
(130 237)
|
(290 454)
|
(276 664)
|
(269 847)
|
(267 102)
|
(12 562)
|
(9 979)
|
|
| Other Items |
20 000
|
(500)
|
200 014
|
191 749
|
(449 908)
|
(449 408)
|
(649 922)
|
(631 608)
|
330 281
|
0
|
0
|
330 303
|
91 072
|
0
|
|
| Cash from Investing Activities |
(502 268)
N/A
|
(513 907)
-2%
|
(425 035)
+17%
|
(528 930)
-24%
|
(760 313)
-44%
|
(774 810)
-2%
|
(872 042)
-13%
|
(761 845)
+13%
|
39 827
N/A
|
53 617
+35%
|
60 434
+13%
|
63 201
+5%
|
78 510
+24%
|
81 093
+3%
|
|
| Financing Cash Flow | |||||||||||||||
| Net Issuance of Common Stock |
1 030 000
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(15 169)
|
(10 020)
|
3 007
|
95 316
|
729 676
|
737 123
|
668 815
|
640 479
|
(243)
|
(489)
|
51 385
|
(11 304)
|
(3 318)
|
(10 122)
|
|
| Other |
(44 335)
|
6 340
|
(8 295)
|
(63 181)
|
(2 224)
|
(447)
|
63 460
|
67 044
|
493
|
(363)
|
(61 534)
|
1 890
|
396
|
(1 980)
|
|
| Cash from Financing Activities |
970 496
N/A
|
(3 680)
N/A
|
(5 288)
-44%
|
32 135
N/A
|
727 452
+2 164%
|
736 677
+1%
|
732 275
-1%
|
707 523
-3%
|
249
-100%
|
(852)
N/A
|
(10 148)
-1 091%
|
(9 415)
+7%
|
(2 922)
+69%
|
(12 102)
-314%
|
|
| Change in Cash | |||||||||||||||
| Net Change in Cash |
518 530
N/A
|
(479 345)
N/A
|
(392 300)
+18%
|
(465 508)
-19%
|
16 921
N/A
|
(35 372)
N/A
|
(151 579)
-329%
|
(80 049)
+47%
|
(9 192)
+89%
|
9 692
N/A
|
27 259
+181%
|
(17 236)
N/A
|
(7 445)
+57%
|
(45 304)
-509%
|
|
| Free Cash Flow | |||||||||||||||
| Free Cash Flow |
(471 965)
N/A
|
(475 165)
-1%
|
(587 026)
-24%
|
(689 392)
-17%
|
(260 623)
+62%
|
(322 640)
-24%
|
(233 932)
+27%
|
(155 964)
+33%
|
(339 723)
-118%
|
(319 737)
+6%
|
(292 873)
+8%
|
(338 124)
-15%
|
(95 595)
+72%
|
(124 274)
-30%
|
|
You don't have any saved screeners yet
